1例胆囊炎患者术后预防出血的合理性分析  

Postoperative Prevention of Hemorrhage in One Patient with Cholecystitis and Rationality Analysis of the Use of Hemostatic Drugs

作　　者：杨灿宇[1] 邓丽颖[1] 

机构地区：[1]辉县市人民医院药剂科,河南辉县453600

出　　处：《中国医院用药评价与分析》2014年第7期654-657,共4页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的:探讨胆囊炎患者术后应用止血药预防出血的合理性。方法:通过介绍临床药师参与1例胆囊炎患者术后预防出血的治疗过程,查找相关文献进行总结分析。结果:围术期应慎用止血药,预防术间出血提倡术前、术中用,术后原则上不用;术后应根据患者的凝血功能确定是否应用止血药。结论:临床药师参与临床诊疗过程,可为患者的用药安全提供有力的保障。OBJECTIVE： To analyze the rationality of the postoperative use of hemostatic drugs （for prevention of hemorrhage） in patient with cholecystitis. METHODS： The clinical pharmacist＇s experience in postoperative use of hemostatic drugs （for preven- tion of hemorrhage） in patient with cholecystitis was summarized and analyzed based on the pertinent literature searched. RESULTS： The hemostasis drugs should be used with caution during operation period. The prevention of intraoperative hemorrhage should be achieved by preoperative and intraoperative use of hemostasis drugs. The hemostasis drugs should not be used postoperatively in prin- ciple, and postoperative use of hemostasis drugs should be based on patients＇ blood clotting function. CONCLUSIONS： Clinical pharmacists＇ participating in the clinical diagnosis and treatment serves as a powerful guarantee for patients＇ medication safety.

关 键 词：临床药学 临床药师 胆囊炎 术后预防出血 

分 类 号：R952[医药卫生—药学]